{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T13:23:40Z","timestamp":1696253020140},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10787-015-0230-7","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T02:56:31Z","timestamp":1424746591000},"page":"91-99","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction"],"prefix":"10.1007","volume":"23","author":[{"given":"Oksana","family":"Zayachkivska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazar","family":"Bula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dzvinka","family":"Khyrivska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gavrilyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"key":"230_CR1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1055\/s-2005-870129","volume":"37","author":"S Abid","year":"2005","unstructured":"Abid S, Mumatz K, Jafri W et al (2005) Pill-induced oesophageal injury: endoscopic features and clinical outcomes. Endoscopy 37:740\u2013744","journal-title":"Endoscopy"},{"issue":"2","key":"230_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semdp.2014.02.002","volume":"31","author":"SJ Almashat","year":"2014","unstructured":"Almashat SJ, Duan L, Goldsmith JD (2014) Non-reflux oesophagitis: a review of inflammatory diseases of the oesophagus exclusive of reflux oesophagitis. Semin Diagn Pathol 31(2):89\u201399","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"230_CR3","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1158\/0008-5472.CAN-05-4253","volume":"66","author":"LA Anderson","year":"2006","unstructured":"Anderson LA, Johnston BT, Watson RP, Murphy SJ, Ferguson HR, Comber H, Murray LJ (2006) Nonsteroidal anti-inflammatory drugs and the oesophageal inflammation\u2014metaplasia\u2013adenocarcinoma sequence. Cancer Res 66(9):4975\u20134982","journal-title":"Cancer Res"},{"issue":"9","key":"230_CR4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00042737-200109000-00017","volume":"13","author":"B Avidan","year":"2001","unstructured":"Avidan B, Sonnenberg A, Schnell TG, Budiman-Mak E, Sontag SJ (2001) Risk factors of oesophagitis in arthritic patients. Eur J Gastroenterol Hepatol 13(9):1095\u20131099","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"230_CR5","doi-asserted-by":"crossref","first-page":"e35196","DOI":"10.1371\/journal.pone.0035196","volume":"7","author":"R Blackler","year":"2012","unstructured":"Blackler R, Syer S, Bolla M, Ongini E, Wallace JL (2012) Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence. PLoS One 7:e35196","journal-title":"PLoS One"},{"key":"230_CR6","first-page":"11","volume":"19C","author":"RW Blackler","year":"2014","unstructured":"Blackler RW, Gemic B, Manko A, Wallace JL (2014) NSAID-gastroenteropathy: new aspects of pathogenesis and prevention. Curr Opin Gastroenterol 19C:11\u201316","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"230_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.15386\/cjm.2014.8872.871.mab1","volume":"87","author":"MA Bordea","year":"2014","unstructured":"Bordea MA, Pirvan A, Sarban C, Margescu C, Leucuta D, Samasca G, Miu N (2014) Pill-induced erosive oesophagitis in children. Clujul Med 87(1):15\u201318","journal-title":"Clujul Med"},{"issue":"8","key":"230_CR8","first-page":"1651","volume":"59","author":"N Bula","year":"2014","unstructured":"Bula N, Gavriluk E, Zayachkivska O (2014) Animal model of non-reflux oesophagitis via NSAID-induced injury and modification biosynthesis of hydrogen sulfide. Dig Dis Sci 59(8):1651\u20131652","journal-title":"Dig Dis Sci"},{"issue":"7","key":"230_CR9","doi-asserted-by":"crossref","first-page":"G467","DOI":"10.1152\/ajpgi.00169.2013","volume":"305","author":"MV Chan","year":"2013","unstructured":"Chan MV, Wallace JL (2013) Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments. Am J Physiol Gastrointest Liver Physiol 305(7):G467\u2013G473","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"230_CR10","first-page":"646","volume":"19","author":"GA Ecker","year":"1992","unstructured":"Ecker GA, Karsh J (1992) Naproxen induced ulcerative oesophagitis. J Rheumatol 19(4):646\u2013647","journal-title":"J Rheumatol"},{"issue":"1","key":"230_CR11","first-page":"52","volume":"92","author":"HB El-Serag","year":"1997","unstructured":"El-Serag HB, Sonnenberg A (1997) Association of oesophagitis and oesophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 92(1):52\u201356","journal-title":"Am J Gastroenterol"},{"key":"230_CR12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/apt.12693","volume":"39","author":"F Hvid-Jensen","year":"2014","unstructured":"Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes AM (2014) Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett\u2019s oesophagus: a nationwide study of 9,883 patients. Aliment Pharmacol Ther 39:984\u2013991. doi: 10.1111\/apt.12693","journal-title":"Aliment Pharmacol Ther"},{"key":"230_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1442-2050.2004.00384.x","volume":"17","author":"A Kadayifci","year":"2004","unstructured":"Kadayifci A, Gulsen MT, Koruk M, Savas MC (2004) Doxycycline-induced pill oesophagitis. Dis Oesophagus 17:168\u2013171","journal-title":"Dis Oesophagus"},{"key":"230_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2011.210","volume":"9","author":"A Kandulski","year":"2012","unstructured":"Kandulski A, Malfertheiner P (2012) Gastroesophageal reflux disease\u2014from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol 9:15\u201322","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"230_CR15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.cgh.2014.04.027","volume":"12","author":"N Khalaf","year":"2014","unstructured":"Khalaf N, Nguyen T, Ramsey D, El\u2013Serag HB (2014) Nonsteroidal anti-inflammatory drugs and the risk of Barrett\u2019s oesophagus. Clin Gastroenterol Hepatol 12(11):1832\u20131839","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"230_CR16","first-page":"275","volume":"3","author":"JW Kikendall","year":"2007","unstructured":"Kikendall JW (2007) Pill-induced oesophagitis. Gastroenterol Hepatol 3(4):275","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"230_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-230X-13-85","volume":"13","author":"T Kuramoto","year":"2013","unstructured":"Kuramoto T, Umegaki E, Nouda S, Narabayashi K, Kojima Y, Yoda Y, Higuchi K (2013) Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced oesophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study. BMC Gastroenterol 13(1):85","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"230_CR18","first-page":"409","volume":"61","author":"J Majka","year":"2010","unstructured":"Majka J, Rembiasz K, Migaczewski M, Budzynski A, Ptak-Belowska A, Pabianczyk R, Brzozowski T (2010) Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett\u2019s oesophagus. Lesson from experimental animal model and human subjects. J Physiol Pharmacol 61(4):409","journal-title":"J Physiol Pharmacol"},{"key":"230_CR19","author":"W Marlicz","year":"2014","unstructured":"Marlicz W, Loniewski I, Grimes DS, Quigley EM (2014) Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine. Mayo Clin Proc. doi: 10.1016\/j.mayocp.2014.07.015","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"230_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000219365","volume":"80","author":"IM Modlin","year":"2009","unstructured":"Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Moss SF (2009) Diagnosis and management of non-erosive reflux disease\u2014the Vevey NERD Consensus Group. Digestion 80(2):74\u201388","journal-title":"Digestion"},{"issue":"3","key":"230_CR21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10787-009-0002-3","volume":"17","author":"G M\u00f3zsik","year":"2009","unstructured":"M\u00f3zsik G, Past T, Salam OMA, Kuzma M, Perj\u00e9si P (2009) Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings. Inflammopharmacology 17(3):113\u2013150","journal-title":"Inflammopharmacology"},{"key":"230_CR22","volume-title":"Drug-induced oesophageal injury","author":"V Namasivayam","year":"2013","unstructured":"Namasivayam V, Murray JA (2013) Drug-induced oesophageal injury. Springer, New York"},{"issue":"7","key":"230_CR23","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1053\/j.gastro.2010.02.045","volume":"138","author":"Dang M Nguyen","year":"2010","unstructured":"Nguyen Dang M, Richardson Peter, Hashem B, Serag El (2010) Medications (NSAIDs, statins, proton pump inhibitors) and the risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus. Gastroenterology 138(7):2260\u20132266","journal-title":"Gastroenterology"},{"issue":"1","key":"230_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10620-014-3333-x","volume":"60","author":"T Nguyen","year":"2015","unstructured":"Nguyen T, Tang Z, Younes M, Alsarraj Ramsey D, Fitzgerald S, El-Serag HB (2015) Oesophageal COX-2 expression is increased in Barrett\u2019s oesophagus, obesity, and smoking. Dig Dis Sci 60(1):65\u201373. doi: 10.1007\/s10620-014-3333-x","journal-title":"Dig Dis Sci"},{"issue":"2","key":"230_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.semdp.2014.02.007","volume":"31","author":"NC Panarelli","year":"2014","unstructured":"Panarelli NC (2014) Drug-induced injury in the gastrointestinal tract. Semin Diagn Pathol 31(2):165\u2013175","journal-title":"Semin Diagn Pathol"},{"issue":"01","key":"230_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/gut.2009.190827","volume":"59","author":"N Pandeya","year":"2010","unstructured":"Pandeya N, Webb PM, Sadeghi S, Green AC, Whiteman DC (2010) Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants? Gut 59(01):31\u201338","journal-title":"Gut"},{"key":"230_CR27","volume-title":"Anti-inflammatory drugs in the 21st century, inflammation in the pathogenesis of chronic diseases","author":"KD Rainsford","year":"2007","unstructured":"Rainsford KD (2007) Anti-inflammatory drugs in the 21st century, inflammation in the pathogenesis of chronic diseases. Springer, The Netherlands"},{"issue":"5","key":"230_CR28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","volume":"17","author":"S Sadeghi","year":"2008","unstructured":"Sadeghi S, Bain CJ, Pandeya N, Webb PM, Green AC, Whiteman DC (2008) Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the oesophagus. Cancer Epidemiol Biomark Prev 17(5):1169\u20131178","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"230_CR29","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1158\/0008-5472.CAN-05-4253","volume":"66","author":"WB Saunders","year":"2006","unstructured":"Saunders WB, Anderson LA, Johnston BT, Watson RP, Murphy SJ, Ferguson HR, Comber H, Murray LJ (2006) Nonsteroidal anti-inflammatory drugs and the oesophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 66(9):4975\u20134982","journal-title":"Cancer Res"},{"issue":"2","key":"230_CR30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10620-014-3349-2","volume":"60","author":"JL Schneider","year":"2015","unstructured":"Schneider JL, Zhao WK, Corley DA (2015) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett\u2019s oesophagus. Dig Dis Sci 60(2):436\u2013443. doi: 10.1007\/s10620-014-3349-2","journal-title":"Dig Dis Sci"},{"issue":"3","key":"230_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10787-007-1550-z","volume":"15","author":"RF Souza","year":"2007","unstructured":"Souza RF (2007) Molecular mechanisms of acid exposure in Barrett\u2019s oesophagus. Inflammopharmacology 15(3):95\u2013100","journal-title":"Inflammopharmacology"},{"key":"230_CR32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1248\/cpb.12.465","volume":"12","author":"K Takagi","year":"1964","unstructured":"Takagi K, Kasuya Y, Watanabe K (1964) Studies on the drugs for peptic ulcer. A reliable method for producing stress ulcer in rats. Chem Pharm Bull 12:465\u2013472","journal-title":"Chem Pharm Bull"},{"key":"230_CR33","author":"K Takeuchi","year":"2014","unstructured":"Takeuchi K, Nagahama K (2014) Animal model of acid-reflux oesophagitis: pathogenic roles of acid\/pepsin, prostaglandins, and amino acids. Biomed Res Int. doi: 10.1155\/2014\/53259","journal-title":"Biomed Res Int"},{"issue":"10","key":"230_CR34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/jclinpath-2014-202511","volume":"67","author":"L Voltaggio","year":"2014","unstructured":"Voltaggio L, Lam-Himlin D, Limketkai BN, Singhi AD, Arnold CA (2014) Message in a bottle: decoding medication injury patterns in the gastrointestinal tract. J Clin Pathol 67(10):903\u2013912","journal-title":"J Clin Pathol"},{"issue":"5","key":"230_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/ars.2014.5901","volume":"22","author":"JL Wallace","year":"2015","unstructured":"Wallace JL, Blackler RW, Chan MV, da Silva GJ, Elsheikh W, Flannnigan KL et al (2015) Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal 22(5):398\u2013410. doi: 10.1089\/ars.2014.5901","journal-title":"Antioxid Redox Signal"},{"key":"230_CR36","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","volume":"159","author":"JL Wallace","year":"2010","unstructured":"Wallace JL, Caliendo G, Santagada V, Cirino G (2010) Markedly reduced toxicity of a hydrogen sulfide-releasing derivative of naproxen (ATB-346). Br J Pharmacol 159:1236\u20131246","journal-title":"Br J Pharmacol"},{"issue":"1","key":"230_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11938-004-0027-z","volume":"7","author":"NS Winstead","year":"2004","unstructured":"Winstead NS, Bulat R (2004) Pill oesophagitis. Curr Treatment Options Gastroenterol 7(1):71\u201376","journal-title":"Curr Treatment Options Gastroenterol"},{"key":"230_CR38","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","volume":"20","author":"RC Zanardo","year":"2006","unstructured":"Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20:2118\u20132120","journal-title":"FASEB J"},{"issue":"6","key":"230_CR39","first-page":"48","volume":"9","author":"OS Zayachkivska","year":"2006","unstructured":"Zayachkivska OS (2006) Significance of NO-mediated mechanism in resistance of oesophageal mucosa. Ukr Med Almanac 9(6):48\u201349","journal-title":"Ukr Med Almanac"},{"issue":"2","key":"230_CR40","first-page":"77","volume":"59","author":"O Zayachkivska","year":"2008","unstructured":"Zayachkivska O, Gzregotsky M, Ferentc M, Yaschenko A, Urbanovych A (2008) Effects of nitrosative stress and reactive oxygen scavenging systems in oesophageal physiopathy under streptozotocin-induced experimental hyperglycemia. J Physiol Pharmacol 59(2):77\u201387","journal-title":"J Physiol Pharmacol"},{"issue":"Suppl. 8","key":"230_CR41","first-page":"211","volume":"28","author":"O Zayachkivska","year":"2010","unstructured":"Zayachkivska O, Hrycevych N, Zvir M (2010) Effect of proinflammatory cytokine-mediated mechanism of quality of gastrointestinal restitutio ad integrum. Ann Univ Mariae Curie-Sk\u0142odowska 28(Suppl. 8):211\u2013214","journal-title":"Ann Univ Mariae Curie-Sk\u0142odowska"},{"issue":"10","key":"230_CR42","doi-asserted-by":"crossref","first-page":"e110688","DOI":"10.1371\/journal.pone.0110688","volume":"9","author":"O Zayachkivska","year":"2014","unstructured":"Zayachkivska O, Havryluk O, Hrycevych N, Bula N, Grushka O et al (2014a) Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive oesophagitis. PLoS One 9(10):e110688. doi: 10.1371\/journal.pone.0110688","journal-title":"PLoS One"},{"issue":"2","key":"230_CR43","first-page":"295","volume":"65","author":"O Zayachkivska","year":"2014","unstructured":"Zayachkivska O, Pshyk-Titko I, Hrycevych N, Savytska M (2014b) New insight into oseophageal injury and protection in physiologically relevant animal models. J Physiol Pharmacol 65(2):295\u2013307","journal-title":"J Physiol Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-015-0230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-015-0230-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-015-0230-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T01:35:43Z","timestamp":1566351343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-015-0230-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":43,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1007\/s10787-015-0230-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,25]]}}}